Financhill
Back

NovoCure Stock Predictions

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 52.5% based on the past 7 years of stock performance.
  • NovoCure has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $57.17. The Score for NVCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 52.5% based on the past 7 years of stock performance.

NovoCure Stock Rating

Sell
40
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Medical Instruments & Supplies
Sector:
Healthcare
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
120.03
52-Week Low:
56.06

Prediction Charts

Market Cap:
6.03B
Price in USD:
57.17
Volume:
561.26K
Beta:
1.06

Technical Analysis

SMA50:
80.28
SMA100:
78.99
SMA200:
77.33
52-Wk Change:
-30.41%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 57.17 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-7 75.64 74.88 76.00 74.33
Mar-8 74.60 74.25 75.12 73.24
Mar-9 74.08 70.70 74.44 70.61
Mar-10 70.43 66.21 70.43 65.05
Mar-13 65.98 68.02 69.01 65.40
Mar-14 69.15 67.26 70.11 66.57
Mar-15 66.09 65.58 66.33 64.06
Mar-16 65.23 64.43 65.36 62.67
Mar-17 59.02 57.10 60.42 56.52
Mar-20 57.44 58.45 58.53 56.80
Mar-21 58.45 58.74 59.82 57.99
Mar-22 58.70 56.44 58.70 56.35
Mar-23 56.75 56.82 58.83 56.42
Mar-24 56.35 57.17 57.64 56.06

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.16 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.